Clinical trial
Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441…
NCT00048022 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00048022 |
|---|---|
| Title | Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Dual Integrin Antagonist |
| Start date | Oct 25, 2002 |
| Primary completion | Feb 2, 2004 |
| Completion | Feb 2, 2004 |
| First posted | Oct 25, 2002 |
| Last update posted | Jun 19, 2017 |
| Countries | Puerto Rico, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: